The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Population-based screening for BRAF V600E in metastatic colorectal cancer (mCRC) to reveal true prognosis.
 
Jenny E. Chu
No Relationships to Disclose
 
Benny Johnson
No Relationships to Disclose
 
Van K. Morris
Consulting or Advisory Role - Clinical Genomics
Travel, Accommodations, Expenses - Array BioPharma
 
Kanwal Pratap Singh Raghav
Honoraria - Bayer; Eisai
Consulting or Advisory Role - Bayer (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Lucas Swanson
No Relationships to Disclose
 
Howard John Lim
Honoraria - Eisai; Ipsen; LEO Pharma; Lilly/ImClone; Merck; Roche Canada; Taiho Pharmaceutical
 
Daniel John Renouf
Honoraria - Celgene; Ipsen; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; SERVIER; Shire
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Sharlene Gill
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Lilly; Roche Canada; Shire; Taiho Pharmaceutical
Speakers' Bureau - Taiho Pharmaceutical
 
Robert Wolber
Travel, Accommodations, Expenses - Roche
 
Aly Karsan
No Relationships to Disclose
 
David F. Schaeffer
Consulting or Advisory Role - Amgen; Robarts Clinical Trials
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Jonathan M. Loree
Consulting or Advisory Role - AMGEN; Bayer; Ipsen; Novartis; Taiho Pharmaceutical